Skip to main content
S.C.P.C logo

S.C.P.C — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Filings indexed 1,621 across all filing types
Latest filing 2025-01-10 Director's Dealing
Country TW Taiwan
Listing TW 1720

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
113年12月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders, including directors, executives, and their related parties. It includes data on shares held, increases, decreases, and trust shares. This type of document is typical of insider shareholding disclosures or director's dealings reports. There is no indication of financial statements, earnings data, meeting materials, or legal proceedings. The document is not a report publication announcement or a certification. Therefore, the best fitting category is Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives.
2025-01-10 Chinese
113年12月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current and initial shareholdings, pledged shares, and related party holdings. It is a disclosure of insider shareholdings and changes, typical of a Major Shareholding Notification or Director's Dealing report. There is no indication of financial statements, earnings data, or meeting results. The document is not a report publication announcement or a certification. Given the focus on insider shareholdings and the detailed breakdown by individual insiders, the most appropriate classification is Director's Dealing (DIRS).
2025-01-10 Chinese
113年12月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company providing details about fund lending balances and endorsement guarantees for the current and previous months, including limits and cumulative amounts. It is a short document (613 characters) and contains specific financial data related to fund lending and guarantees, but it does not present a full financial report or comprehensive analysis. It appears to be a regulatory disclosure or compliance update rather than a full report like an Annual Report or Interim Report. Given the nature and length, and that it does not fit other specific categories, it best fits under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory disclosures that do not fit other categories.
2025-01-09 Chinese
113年12月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 生達, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or audit information. The document length is short (771 characters), and it does not appear to be an announcement of a report publication but rather a brief financial data summary. This matches the description of a Fund Information / Factsheet (FS), which is a brief summary of key company financials and market info.
2025-01-09 Chinese
113年12月內部人持股轉讓(事前)
Director's Dealing Classification · 100% confidence The document is a report of a share transfer by an insider (法人董事代表人本人) involving a specific number of shares and transfer method (贈與 - gift). It details the insider's shareholding before and after the transfer, the transfer period, and related information. This matches the definition of Director's Dealing, which reports personal share transactions by company directors and executives (insider trades). The document is short and focused solely on insider share transactions, not on broader financial or corporate reports.
2024-12-30 Chinese
本公司董事會決議大陸地區投資,並代子公司公告對 大陸子公司債權轉增資案。
Capital/Financing Update Classification · 95% confidence The document is a company announcement regarding a board resolution for investment in a subsidiary and capital increase through debt-to-equity conversion. It includes detailed information about the investment amount, related parties, approval dates, and financial data of the subsidiary. The document is relatively short (2189 characters) and is structured as a formal disclosure rather than a full financial report. It does not contain comprehensive financial statements or detailed financial analysis typical of an Annual Report (10-K) or Interim Report (IR). Instead, it is a regulatory announcement about a capital/financing update related to investment and capital structure changes. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-12-17 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.